Elicio Capital Lease Obligations from 2010 to 2024

ELTX Stock   4.88  0.20  3.94%   
Elicio Therapeutics Capital Lease Obligations yearly trend continues to be fairly stable with very little volatility. Capital Lease Obligations is likely to outpace its year average in 2024. Capital Lease Obligations is the total obligations of Elicio Therapeutics under capital leases, which are lease agreements that transfer substantially all risks and rewards of ownership to the lessee. View All Fundamentals
 
Capital Lease Obligations  
First Reported
2010-12-31
Previous Quarter
6.9 M
Current Value
7.3 M
Quarterly Volatility
2.7 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Elicio Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Elicio Therapeutics' main balance sheet or income statement drivers, such as Interest Income of 391.6 K, Depreciation And Amortization of 828.2 K or Selling General Administrative of 6.8 M, as well as many indicators such as Price To Sales Ratio of 0.57, Dividend Yield of 0.0 or PTB Ratio of 3.89. Elicio financial statements analysis is a perfect complement when working with Elicio Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Elicio Therapeutics Correlation against competitors.
For more information on how to buy Elicio Stock please use our How to Invest in Elicio Therapeutics guide.

Latest Elicio Therapeutics' Capital Lease Obligations Growth Pattern

Below is the plot of the Capital Lease Obligations of Elicio Therapeutics over the last few years. Elicio Therapeutics capital lease obligations are the amount due for long-term lease agreements that are nearly equivalent to Elicio Therapeutics asset purchases. For example, Elicio Therapeutics can use a capital lease to finance the purchase of an asset without ever buying it. A capital lease gives companies such as Elicio Therapeutics control over an asset for a big portion of its life. It is the total obligations of a company under capital leases, which are lease agreements that transfer substantially all risks and rewards of ownership to the lessee. Elicio Therapeutics' Capital Lease Obligations historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Elicio Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Capital Lease Obligations10 Years Trend
Slightly volatile
   Capital Lease Obligations   
       Timeline  

Elicio Capital Lease Obligations Regression Statistics

Arithmetic Mean2,051,793
Geometric Mean0.00
Coefficient Of Variation131.00
Mean Deviation2,067,473
Median867,604
Standard Deviation2,687,810
Sample Variance7.2T
Range7.5M
R-Value0.65
Mean Square Error4.5T
R-Squared0.42
Significance0.01
Slope390,636
Total Sum of Squares101.1T

Elicio Capital Lease Obligations History

20247.3 M
20236.9 M
20227.5 M
2021null
2020439.4 K

About Elicio Therapeutics Financial Statements

Elicio Therapeutics investors use historical fundamental indicators, such as Elicio Therapeutics' Capital Lease Obligations, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Elicio Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Capital Lease Obligations6.9 M7.3 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Elicio Stock Analysis

When running Elicio Therapeutics' price analysis, check to measure Elicio Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elicio Therapeutics is operating at the current time. Most of Elicio Therapeutics' value examination focuses on studying past and present price action to predict the probability of Elicio Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elicio Therapeutics' price. Additionally, you may evaluate how the addition of Elicio Therapeutics to your portfolios can decrease your overall portfolio volatility.